<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2145">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04339686</url>
  </required_header>
  <id_info>
    <org_study_id>POWER-COVID_CT</org_study_id>
    <nct_id>NCT04339686</nct_id>
  </id_info>
  <brief_title>Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.</brief_title>
  <official_title>Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. Comparison to Virological Testing and Multiparametric Gold Standard</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All patients included in this search will be on anonymized file: Symptomatic patients
      consulting for suspicion of COVID 19 with indication to a screening (RT-PCR, Scanner)
      according to the criteria of the Ministry of Health.

      To evaluate the diagnostic performance of chest CT in screening for COVID-related lung injury
      in patients with a clinical suspicion of COVID.

      CT scan results for COVID according to French thoracic imaging society will be dichotomized
      into evocative or compatible (considered positive) non-evocative (considered negative) The
      results will be compared to the gold standard corresponding to a multiparametric element: the
      discharge summary.

      Ct Scan performance will be recorded and analyzed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2020</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic performance of chest CT in screening for pulmonary lesions in clinical suspicions of COVID.</measure>
    <time_frame>1 month</time_frame>
    <description>CT Report will dichotomized into evocative or non-evocative for COVID-related lung injury.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the diagnostic performance of chest CT and RT-PCR in COVID 19 at the initial consultation (screening).</measure>
    <time_frame>1 month</time_frame>
    <description>Initial virological RT-PCR results: positive or negative depending on the laboratories of the institutions.
Scanner results according to French Thoracic Imaging Society.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">56000</enrollment>
  <condition>The Gold Standard for Current SARS CoV2 Detection is RT-PCR</condition>
  <arm_group>
    <arm_group_label>Suspicion of COVID 19</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Thoracic CT Scan</intervention_name>
    <description>Retrospective analysis of the thoracic CT scan results compared to final discharge summary</description>
    <arm_group_label>Suspicion of COVID 19</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients suspected of COVID 19 consulting for diagnostic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients suspected of COVID 19 consulting for diagnostic

        Exclusion Criteria:

          -  Delay between RT-PCR and Thoracic Scan greater than 6 days.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guillaume HERPE</last_name>
    <phone>681196778</phone>
    <phone_ext>+33</phone_ext>
    <email>guillaume.herpe@chu-poitiers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume HERPE</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

